Authors
Latest:
The Importance of Age Diversity in Clinical TrialsAge diversity in clinical trials benefits both the patient experience and the success of the trial.
Latest:
Patient Engagement Surveys in Clinical Trials: Dos, Don’ts and How They HelpThis article will address concerns and look at how the pragmatic implementation of surveys in today’s clinical trials can provide valuable insight into patient satisfaction levels, motivators, likelihood to follow study requirements and information retention.
Latest:
How to Avoid Common Pitfalls of Market LandscapingKey tips and resources to help evade the common traps of market landscaping-today an increasingly high-stakes and comprehensive task during clinical development.
Latest:
New ICH Guidelines Address Industry InefficiencyIn this article, Crissy MacDonald reviews the key changes in ICH E6 (R2), discuss the challenges organizations are facing, and present actionable recommendations for organizations to implement now.
Latest:
Using Feasibility Tools to Build Better Sponsor–Investigator RelationshipsFeasibility, the evaluation of whether a particular trial can recruit enough of the right patients so that the study completes on time and within budget, is arguably the most critical part of the clinical trial process.
Latest:
Recent Trends in Clinical Trials for Coronary DiseasesIn this study, Clinical Trials Transformation Initiative’s database for aggregate analysis of ClinicalTrials.gov was used to evaluate the number of ongoing and completed interventional clinical trials for various coronary diseases.
Latest:
Navigating the Complexities of Drug-Biomarker Co-DevelopmentSuccess in developing targeted medicines means companies need a companion diagnostic strategy, the expertise, and more.
Latest:
Clinical Trials In a Dish: A Revolution BeginsThe emergence of CTiD offers the potential to remove future clinical failures much earlier in the process-and pave way for gains in R&D productivity.
Latest:
Clinical Trials In a Dish: A Revolution BeginsThe emergence of CTiD offers the potential to remove future clinical failures much earlier in the process-and pave way for gains in R&D productivity.
Latest:
Clinical Trials In a Dish: A Revolution BeginsThe emergence of CTiD offers the potential to remove future clinical failures much earlier in the process-and pave way for gains in R&D productivity.
Latest:
Challenging the ‘Site-first’ Status Quo in Patient EnrollmentCase study highlights a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.
Latest:
Challenging the ‘Site-first’ Status Quo in Patient EnrollmentCase study highlights a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.
Latest:
The Future of Mobility and MedicineThe role of the cloud in realizing the practical benefits of mHealth in clinical trials.
Latest:
The Status of Ebola VaccinesMarket players working on development of vaccines to fight against the virus are focused on clinical trials and look forward to gaining approval from regulatory bodies.
Latest:
Designing and Executing a Gene Testing Counseling and Disclosure ProcessAlzheimer's Prevention Initiative's discusses a genetic counseling and disclosure model for its Generation Program.
Latest:
FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug DevelopersJanuary 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Latest:
Leveraging Modeling & Simulation in OncologyHow the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.
Latest:
Pediatric Oncology Clinical Trials in Sub-Saharan AfricaThe region is significantly underrepresented in clinical development activity targeting childhood cancer.
Latest:
Complex, Puzzling, Ill-Defined: Challenges in Assessing PTSDA recurring challenge in assessing and treating Post-Traumatic Stress Disorder or PTSD is the inherently complex, ill-defined, and sometimes downright puzzling nature of its symptoms.
Latest:
Why Data Integrity Should be an Integral Part of the Pharma Biotech Industry CultureData integrity is the essence of GMP, the cornerstone of how the industry operates, and it is vital that all organizations embrace it to survive the rapidly changing life sciences landscape.
Latest:
Categorical Data AnalysisA review of different statistical methods for data types and models used during research.
Latest:
Evolution of Clinical Trial Agreement Review in Malaysia Through Clinical Research MalaysiaA reduction of Clinical Trial Agreement Review times has caused rapid development in Malaysian clinical trials.
Latest:
Evolution of Clinical Trial Agreement Review in Malaysia Through Clinical Research MalaysiaA reduction of Clinical Trial Agreement Review times has caused rapid development in Malaysian clinical trials.
Latest:
Advancing Oncology Drug Development with ePRO SolutionsFor drug developers, oncology therapeutics arguably represent both the greatest opportunity and challenge for putting patients at the center. This ebook covers series strategies for Advancing Oncology Drug Development with ePRO Solutions.
Latest:
How Data and Analytics Can Improve Clinical Trial FeasibilityThese seven key building blocks for success are outlined to help companies develop and implement a data-and-analytics-driven approach to clinical trial feasibility.
Latest:
4 Key Actions ClinOps Can Take Now to Avoid DisruptionsBiopharmaceutical sponsors should make urgent decisions now to plan for continued clinical research in the coming months.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
